Insiders Zymeworks Inc.

Equities

ZYME

US98985Y1082

Market Closed - Nasdaq Other stock markets 21:00:00 08/05/2024 BST			5-day change	1st Jan Change
9.06 ^USD	-0.66%		+3.42%	-12.80%

05-02	Transcript : Zymeworks Inc., Q1 2024 Earnings Call, May 02, 2024
05-02	Zymeworks Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zymeworks Inc. Removes Dr. Christopher Astle from the Positions of Senior Vice President	04-04	CI
Zymeworks Inc. Announces the Composition of the Committees	03-28	CI
Zymeworks Inc. Announces Appointment of Neil Gallagher to Its Board of Directors and as Member of the Research and Development Committee, Effective April 2, 2024	03-28	CI
Zymeworks Inc. Appoints Scott Platshon as Director	02-22	CI
Zymeworks Announces Appointment of Dr. Alessandra Cesano to Its Board of Directors	02-08	CI
Zymeworks Insider Sold Shares Worth $257,845, According to a Recent SEC Filing	01-09	MT
Zymeworks Appoints Jeffrey Smith as Chief Medical Officer; Cash Runway Extended	01-04	MT
Zymeworks Inc Announces Additional Leadership Appointments	01-04	CI
Zymeworks Inc. Announces Changes to its Board	12-08	CI
Zymeworks Inc Announces Resignation of Lota Zoth as Member of the Board of Directors	16/10/23	CI
Zymeworks Inc. Announces Board Changes, Effective June 30, 2023	29/06/23	CI
Zymeworks Inc. Announces Executive Changes	18/05/23	CI
Zymeworks Inc. Announces Appointment of Derek J. Miller to Its Board of Directors	10/04/23	CI
Zymeworks Updates on Cash Resources; Chief Medical Officer to Depart Amid Internal Reorganization	04/01/23	MT
Zymeworks Inc. Removes Neil Josephson from the Position of Chief Medical Officer	04/01/23	CI
Zymeworks Inc. has Changed its Name to Zymeworks BC Inc	13/10/22	CI
Zymeworks Names COO Neil Klompas as President	05/08/22	MT
Zymeworks Inc. Appoints Mr. Neil Klompas as President	05/08/22	CI
Zymeworks Plans to Become a Delaware Corporation; Name, Brand, Ticker Symbol to Remain Unchanged	15/07/22	MT
Zymeworks Appoints Paul Moore Chief Scientific Officer	27/06/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Zymeworks Inc.

Equities

ZYME

US98985Y1082

Insiders

Filters